No. 21-1567 |
|
Title: |
Biogen International GmbH, et al., Petitioner v. Mylan Pharmaceuticals Inc. |
Docketed: | June 15, 2022 |
Lower Ct: | United States Court of Appeals for the Federal Circuit |
Case Numbers: | (2020-1933) |
Decision Date: | November 30, 2021 |
Rehearing Denied: | March 16, 2022 |
Jun 14 2022 | Petition for a writ of certiorari filed. (Response due July 15, 2022) Petition Appendix Certificate of Word Count Proof of Service |
Jun 30 2022 | Motion to extend the time to file a response from July 15, 2022 to August 15, 2022, submitted to The Clerk. Main Document |
Jul 01 2022 | Motion to extend the time to file a response is granted and the time is extended to and including August 15, 2022. |
Jul 11 2022 | Brief amicus curiae of Chemistry and the Law Division of the American Chemical Society filed. Main Document Proof of Service Certificate of Word Count |
Jul 14 2022 | Brief amicus curiae of New England Legal Foundation filed. Main Document Proof of Service Certificate of Word Count |
Jul 15 2022 | Brief amici curiae of Pharmaceutical Research and Manufacturers of America, et al. Main Document Proof of Service Certificate of Word Count |
Aug 15 2022 | Brief of respondent Mylan Pharmaceuticals Inc. in opposition filed. Main Document Proof of Service Certificate of Word Count |
Aug 30 2022 | Reply of petitioners Biogen International GmbH and Biogen MA Inc. filed. (Distributed) Main Document Proof of Service Certificate of Word Count |
Aug 31 2022 | DISTRIBUTED for Conference of 9/28/2022. |
Oct 03 2022 | Petition DENIED. |